NovaBay Pharmaceuticals (NBY) Stock: Rebrands as Stablecoin Development Corp, Acquires $147M in SKY Tokens

TLDR

• NovaBay becomes SDEV, pivoting from healthcare to digital finance.
• Executes $134M private placement and major SKY token acquisition.
• Holds 2.06B SKY tokens, staking to earn 26.6M additional tokens.
• Staking and governance drive long-term protocol influence and rewards.
• Stablecoin strategy central to SDEV’s on-chain finance and treasury plan.

NovaBay Pharmaceuticals (NBY) surged 20.7% intraday to $1.4001 after announcing a full rebrand. The company changed its name to Stablecoin Development Corporation and ticker to SDEV. The firm disclosed a $134 million private placement and a major acquisition of SKY tokens.

NovaBay Pharmaceuticals, Inc., NBY
The firm executed a 1-for-5 reverse stock split in February 2026 to align with the restructuring. SDEV aims to become a public market vehicle focused on stablecoin ecosystems. The move represents a complete shift from healthcare to digital finance strategy.

The private placement involved R01 Fund LP, Framework Ventures, Tether Investments, and Sky Frontier Foundation. SDEV issued pre-funded warrants covering 167.5 million shares for gross proceeds of $134 million. Proceeds have funded additional SKY token purchases and staking activities.

Strategic Token Accumulation and Staking Rewards

SDEV currently holds approximately 2.06 billion SKY tokens, representing 8.78% of total token supply. Over half of the holdings were purchased on the open market at an average price near $0.065. The remainder was acquired through the January 2026 private placement, which included cash and stablecoins.

The company began staking SKY tokens to generate protocol-level rewards and has earned 26.6 million tokens to date. Staking yields depend on protocol governance rules and participation levels. This approach creates a long-duration position with ongoing digital asset returns.

Additional SKY acquisitions reflect a strategy to maintain governance influence within the Sky protocol. The token holdings allow participation in decision-making for the USDS stablecoin ecosystem. SDEV has structured the portfolio for orderly market impact and sustained staking benefits.

On-Chain Holding Company and Stablecoin Strategy

SDEV operates under an on-chain holding company model to engage in long-term protocol-level activities. The framework permits selective monetization for corporate liquidity or tax purposes while maintaining governance participation. Only SKY tokens meet the company’s operating and risk management framework criteria.

The company views stablecoins as integral to digital finance infrastructure, enabling settlement, payments, and on-chain capital activity. Yield-bearing stablecoins allow deployment across lending, real-world assets, and protocol-generated revenue streams. Institutional involvement, including Tether Investments, signals growing support for regulated stablecoin participation.

The January 2026 private placement included warrants with staggered exercise schedules to support market stability. Each purchaser faces a 10% daily trading cap relative to 30-day average volume. This ensures orderly token distribution and reinforces long-term alignment with SDEV’s strategy.

SDEV’s pivot from pharmaceuticals to digital assets places it among firms leveraging crypto governance tokens for corporate treasury purposes. The company now combines staking rewards, governance influence, and market participation into a single strategy. SKY token accumulation and stablecoin engagement represent the core of its redefined business model.

The post NovaBay Pharmaceuticals (NBY) Stock: Rebrands as Stablecoin Development Corp, Acquires $147M in SKY Tokens appeared first on CoinCentral.